News & Updates

In the treatment of patients with moderate-to-severe chronic low back pain, the use of infliximab does not yield meaningful reductions in pain-related disability when compared with placebo, as shown in a study.

New drug applications approved by US FDA as of 16-31 December 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Osteoporotic fractures do not occur frequently among kidney transplant recipients but when they do, they contribute to increased risks of death and allograft loss, according to a retrospective cohort study.

Factors such as male sex, older age, and prior X-ray examination are linked to an increased risk of major adverse cardiovascular events (MACE) and malignancies in patients with rheumatoid arthritis, according to a study from Japan.

Treatment with proton pump inhibitors (PPIs) may contribute to a higher incidence of intestinal Behçet Disease (BD) in patients with BD, suggest the results of a study.

Patients with Takayasu arteritis (TA) who develop serious infections are susceptible to increased mortality, reveals a recent study.

Researchers from the University College London (UCL) in the UK have developed a high-resolution three-dimensional (3D) photoacoustic scanner based on the Fabry-Perot (FP) ultrasound sensor concept and examined its potential as a tool for clinical vascular imaging.